• AAPL 172.4
  • TSLA 246.53
  • AMZN 124.72
  • BTC-USD 27532.4902
  • ETH-USD 1646.3324
  • EURUSD 1.0505
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. US /
  3. AMBFF.US

Ambu A/S (AMBFF PINK) stock market data APIs

$10.6 0(0%) as of October 3, 2023

Ambu A/S Financial Data Overview

10.6
10.6
-
10.6
10.6
9.26-16.64
2 722 M
232 M
4 679 M
0.028
0.0036
0.631
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'AMBFF',
Type: 'Common Stock',
Name: 'Ambu A/S',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00GD70Y81',
ISIN: NULL,
CUSIP: NULL,
CIK: NULL,
EmployerIdNumber: '',
FiscalYearEnd: 'December',
IPODate: '1998-08-18',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Medical Devices',
GicSector: 'Health Care',
GicGroup: 'Pharmaceuticals, Biotechnology & Life Sciences',
GicIndustry: 'Biotechnology',
GicSubIndustry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,
}

Ambu A/S Fundamental Data is available in our Financial Data APIs

  • Net Revenue 4 679 M
  • EBITDA 360 M
  • Earnings Per Share -0.02
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $49.99 See full price
Get sample
of Fundamental API Data

Get Ambu A/S Earnings via APIs

  • Latest Release 2023-06-30
  • EPS/Forecast NaN

Get Ambu A/S End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Ambu A/S latest news via APIs

AMBU FINANCIAL CALENDAR FOR 2023/24

Ambu A/S This financial calendar lists the expected release dates of Ambu’s financial announcements for the financial year 2023/24, as well as the date of Ambu’s Annual General Meeting. 2023 8 ...

INTERIM REPORT FOR Q3 2022/23

Ambu A/S In Q3 2022/23, Ambu delivered 8% organic revenue growth and a 7.6% EBIT margin. This was driven by Endoscopy Solutions growing 23%, due to high double-digit growth within urology and ENT, an...
Still have any questions?

Or need any other data for equities, funds or ETFs? Send us an email.

support@eodhistoricaldata.com
We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy.